Evidence map›Paper›PMID 40636667›Full record

ArticleCureus2025

A Rare Case of Crystal-Storing Histiocytosis of the Breast in a Patient With Undifferentiated Connective Tissue Disease.

Mariel Bedell, Rana Naous

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mariel BedellPathology, University of Pittsburgh Medical Center, Pittsburgh, USA.
Rana NaousPathology, University of Pittsburgh Medical Center, Pittsburgh, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crystal-storing histiocytosis (CSH) is a rare entity usually presenting microscopically as sheets of histiocytes with intralysosomal accumulation of refractile, crystalline substances. CSH is most often the result of monoclonal immunoglobulin light chain deposition in the setting of a plasma cell neoplasm or lymphoma with plasma cell differentiation. However, this condition may arise in association with autoimmune, inflammatory, infectious, and drug-related etiologies and can harbor polyclonal immunoglobulins or other crystalline materials. It usually presents in a localized fashion, with the bone marrow being the most frequent site, but may also involve multiple anatomical sites. CSH is typically identified incidentally without clinical suspicion and can be challenging to detect histologically. However, in rare cases, it may be the sole presenting sign in an undiagnosed malignancy or immune disorder. Here, we describe an unusual case of CSH, occurring as an isolated breast mass in association with an undifferentiated connective tissue disease (UCTD) with inflammatory arthritis, features of Sjögren's (Sicca) syndrome, and subsequent laboratory findings concerning for antiphospholipid syndrome.

Indexed as

breastconnective tissue diseasecrystalhistiocytosislymphoproliferative disorderstoring

Identifiers

PMID40636667
PMCPMC12239935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.